Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MILWAUKEE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of July 31, 2025 totaled...
-
EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), a precision genetic medicines company committed to developing curative therapeutics for patients...
-
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 31, 2025, short interest in 3,285 Nasdaq Global MarketSM securities totaled 13,683,072,188 shares compared with...
-
WOOSTER, Ohio, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Main Street Financial Services, Corp. (OTCQX: MSWV), the holding company for Main Street Bank, is pleased to announce the opening of a full-service...
-
ROAD TOWN, British Virgin Islands, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ozak AI has officially crossed the $1.7 million mark in its Stage 4 presale, with over 108 million $OZ tokens already sold to...
-
Boston, Aug. 11, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Quantum Computing: Technologies and Global Markets to 2030,” the market is projected to grow from $1.6...
-
Salt Lake City, Utah, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Umbra, a leading American space technology company, announced today the official launch of its new Space Systems business unit at the Small...
-
Boston, Aug. 11, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Global Graphene Market” is projected to grow from $694.4 million in 2025 to reach $2.3 billion by the end...
-
Houston, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Online Slots for Real Money 2025: Jackpota Launches New Slot Games Jackpota has launched new slot games that enhance the gaming environment, making it...
-
Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2.Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion...